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Abstract
Nerve growth factor induces PCI2 cells to differentiate
from a chromaffin cell to a sympathetic neuronal
phenotype. In contrast￿ PCI2 cells, which stably express
Wnt-1, a secreted signaling factor required for
development of mammalian midbrain and cerebellum, fail
to express differentiation-specific genes in response to
nerve growth factor. Analysis of factors binding to E box-
containing regulatory elements of the terminal
differentiation gene encoding peripherin suggested a
differentiation-specific control of expression of helix-
loop-helix transciiptional regulators. Specifically, the
MASH-I (mammalian achaete-scute homologue) helix-
loop-helix transcription factor, which plays a positive role
in neuronal differentiation, is reduced in Wnt-IIPCI2
cells, and HES-1, a negative regulator of MASH-I, is
increased. These data suggest that the differentiation
block may result from induction of HES-1. Wnt-1/PCI2
cells also proliferate more rapidly and express increased
levels of cyclin Dl. Thus, Wnt-1 may block the
differentiation and enhance the proliferation of PCI2 cells
by activating HES-1 and cyclin Dl and repressing
MASH-I.
Introduction
The terminal stages of neuronal differentiation follow a
complex program of gene regulation and cell cycle arrest.
The response of the rat pheochromocytoma PCi 2 cell line
(1) to NGF3 provides a model for this program. NGF in-
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duces PC12 to differentiate from a chromaffin-like cell to
sympathetic neuronal-like cells that are electrically excit-
able, extend neurite processes, express differentiation-
specific genes, and arrest their growth (1-6). PC12 cells
also respond to the Wnt-1 protein (7-9). Wnt-1 is one of a
class of highly conserved, secreted signaling proteins, the
gene of which was first identified in mouse mammary
tumor virus-induced mammary cancers (1 0-1 2), but which
is normally expressed in the developing brain (13-15)
where it is required for midbrain and cerebellar develop-
ment (16-19). The Drosophila Wnt-1 orthologue, the seg-
ment polarity gene wg, encodes a secreted signaling pro-
tein (20-24) with multiple roles in development (reviewed
in Refs. 25 and 26). Several genes, including dishevelled,
zeste-white-3, and armadillo, have been identified which
transduce the wg signal (27-29).
The lack of a functional, cell-free soluble form of Wnt-1 is
a major obstacle to studying Wnt-1 signaling. To develop a
cell culture assay for Wnt-1 ,Shackleford et a!. (9) expressed
the Wnt-1 cDNA in PCi 2 cells, one of the few cell types in
which an introduced Wnt-1 gene causes morphological and
biochemical alterations. Many of these alterations, including
loss of responsiveness to NGF, reduced expression of chro-
maffin and neural markers, and elevated expression of cer-
tam proto-oncogenes, suggest that Wnt-1 blocks or reverses
the PCi 2 differentiation pathway (8, 9, 30, 31). Furthermore,
PC12 cells are derived from the neural crest lineage, which
arises from a Wnt-1 -expressing region of the neural tube (32,
33). Thus, PCi 2 cells may provide a physiologically relevant
cellular context in which to study Wnt-1 -dependent regula-
tion of neuronal differentiation.
To analyze the mechanism by which Wnt-1 alters PCi 2,
we examined the effects of Wnt-1 on PCi 2 differentiation.
We show that Wnt-1/PC12 cells express neither the inter-
mediate filament protein peripherin, nor factors binding to
a positive acting DNA element of the peripherin promoter,
which contains a bHLH protein binding site. Furthermore,
the mRNA and protein for the bHLH transcription factor,
MASH-i ,are diminished in Wnt-i/PC12 cells, whereas the
mRNA for the neuroregulatory bHLH transcription factor
HES-1 is elevated. MASH-i is a neuronal-specific homo-
logue of the Drosophila neuronal determination genes
achaete and scute (34, 35). HES-i , like its Drosophila
homologues hairy and E[spl] (36-38), acts as a negative
regulator of neurogenesis (39, 40). Wnt-1/PC1 2 cells also
proliferate more rapidly and express elevated levels of the
G1 cyclin, cyclin Dl. These changes in Wnt-1/PC12 cells
provide a basis for negative control of neural differentia-
tion by Wnt-1.A ￿ 2 3
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Fig. 1. Reduced expression of the peripherin gene in Wnt-1-trans-
formed PC12 cells. A, peripherin mRNA levels are diminished in Wnt-
1/PC12 cells. Northern blot analysis was performed as described in
“Materials and Methods” with 30 ug of cytoplasmic RNA and random
prime-labeled cDNAs. RNA was obtained from antisense Wnt-i/PC12
cells (Lane 1) and Wnt-1/PC12 clones 2, 4, and 5 (Lanes 2-4, respec-
tively). Blots were also probed with 32P-Iabeled G3PDH cDNA to con-
trol for amount of RNA in each well. Quantitation was by phosphorim-
ager analysis. B and C, gel mobility shift assays of proteins binding to
regulatory elements of the peripherin gene promoter. Nuclear extracts
(ext) were prepared from Wnt-1-transformed PC12 cells or control
antisense Wnt-1/PC12 cells, according to the method of Schreiber et
a!. (96). Gel shift assays and oligonucleotide competitions (comp) were
performed as described in “Materials and Methods.” Oligonucleotides
(41) were as follows (top strand): B, peripherin NRE (-191 to -161):
5’AGGUGGGGAATCAAGCAGGCAGGGCGCCAGCAACC3’. C, pe-
ripherin DPE (W; -2578 to -2550): 5’CATGTATGTGTTAAGCATGTG-
CATAGATT3’. Peripherin DPE mutant (M; -2569 to -2550): 5’GTTA-
AGCGACCACATAGATT3’. Arrows, the sequence-specific DNA-protein
complexes interacting at the peripherin NRE (B) or DPE (C).
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Results
Repression of the Terminal Differentiation Gene Periph-
erin in Wnt-1 -transformed PC12 Cells. PCi 2 cells express-
ing Wnt-1 show dramatic morphological and biochemical alter-
ations (7-9, 31) that are evident in mixed pools and clones of
Wnt-1 -transformed PCi 2 cells, but are absent in two control
cell lines, MV7fs/PC12 and antisense Wnt-1/PC12. MWfs ex-
presses a frameshift mutant of Wnt-1 ,which codes for a non-
functional protein (7). Antisense Wnt-1/PC12 cells express
Wnt-1 in the antisense orientation and, because PCi 2 cells do
not express endogenous Wnt-1 ,thus serve as a control (9). The
two control cell lines resemble wild-type PCi 2 cells and are
round and refractile, make few cell-cell contacts, and are poorly
adherent. In contrast, mixed pools of Wnt-1 -transformed PC12
cells (MV7Wnt-1/PC12) and the three Wnt-1-transformed
clones (clones 2, 4, and 5) are flat, make extensive cell-cell
contacts, and are strongly adherent.
Northern blotting revealed that peripherin mRNA is ex-
pressed in control Wnt-1/PC1 2 antisense cells (Fig. 1A, Lane
1), but not in three Wnt-1/PC12 clones (Fig. 1A, Lanes 2-4).
Peripherin expression is controlled by at least two DNA ele-
ments (41). One, the DPE, is a positive regulator and contains
an E box element with the sequence of a HLH protein binding
site (41-43). The second, the NRE, inhibits peripherin gene
activity and binds the factor NF-1 (41,44). After NGF treat-
ment, the DPE undergoes a change in protein binding that
suggests the release of a repressor. Electrophoretic mobility
shift assays confirmed the previous finding (41) that the
pci 2 cell extract complex with the NRE (Fig. 2B, Lanes 2 and
3) migrates more slowly than the corresponding NGF/PC12
cell complex (Fig. 2B, Lanes 4 and 5). NRE complexes with
extracts from three Wnt-1/PC12 clones resembled those of
undifferentiated PC12 (Lanes 6-1 1), in agreement with the
lack of peripherin expression in Wnt-1/PC12 cells. Although
the second element, the DPE, also formed E box-dependent
complexes with PCi 2 and NGF/PC1 2 extracts (Fig. 2C,
Lanes 2-7), strikingly, no DPE complexes were detected with
extracts from the three Wnt-1/PC12 clones (Fig. 2C, Lanes
8-12). Thus, a DPE-binding protein, presumably a bHLH
transcription factor, is absent from Wnt-1/PC1 2.
Repression of MASH-I and Induction of HES-I in Wnt-
I-transformed PCI2 Cells. The MASH-i HLH protein is
expressed in PCi 2 cells and functions in neuronal differen-
tiation (34, 35, 45-48). MASH-i is thought to function either
during neuronal determination, or early neuronal differentia-
tion (45, 48, 49). It is only modestly regulated by NGF in PCi 2
cells, which presumably are already committed to the neu-
ronal lineage (46). In P1 9 cells, which probably represent an
earlier differentiation state than PCi 2 cells (50-52), retinoic
acid induces MASH-i coincident with the expression of neu-
ral markers (46). This suggests that MASH-i expression is
related to neural commitment and raises the possibility that
Wnt-i may alter the PCi 2 differentiation state by regulating
MASH-i expression. The peripherin DPE contains an E box
that is a potential MASH-i binding site. The failure of Wnt-
i/PC12 extracts to form a DPE complex-a complex requir-
ing an intact bHLH binding site-suggested that levels of a
bHLH factor, possibly MASH-i ,may be reduced in Wnt-i/
pci 2 cells. Indeed, Northern and Western analyses revealedA 1 2 3 4 B ￿ 2 3 456
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Fig. 2. Diminished expression of MASH-i and elevated expression of HES-1 in Wnt-1-transformed PC12 cells. A, MASH-i mRNA levels are decreased
in Wnt-i/PC12 cells. Northern blot analysis was performed as described in “Materials and Methods.” RNA from antisense Wnt-1/PC12 cells (Lane 1) and
Wnt-1/PC12 clones 2, 4, and 5 (Lanes 2-4, respectively). B, Western blot analysis of MASH-i protein expression in Wnt-1 PC12 cells. Protein lysates were
prepared from Wnt-i/PC12 cell clones 2, 4, and 5 (Lanes 4-6), antisense Wnt-i PC12 cells (Lane 3), and PC12 cells untreated (Lane 1) or treated with NGF
for 5 days (Lane 2). Immunoblotting was performed as described in “Materials and Methods.” Nitrocellulose was stained with Ponceau-S to check protein
loading. C, HES-i expression in wild type PC12 cells (Lane 1), control antisense Wnt-1/PC12 cells (Lanes 2 and 5), and three clones (2, 4, and 5) of
Wnt-1/PC1 2 cells (Lanes 6-8). HES-1 expression was also examined in PCi 2 cells infected with retrovirus transducing either Wnt-1 (MV7Wnt-1 ; Lane 4)
or the empty vector MW (Lane 3). The cells were grown as pools of 50-i 00 G41 8-resistant colonies to minimize clonal variation (7). D, HES-1 represses
the MASH-i promoter. A MASH-i promoter-reporter construct containing 10 kb of MASH-i genomic sequence that lie 5’ to the transcription start site linked
to the LACZ reporter gene, which was followed by 3 kb of MASH-i 3’ untranslated region sequence (55), was assayed for repression by HES-1 . PC12 cells
were cotransfected with 3 j￿g of the MASH-i promoter construct and either 10 ￿g (Lane 2) or 20 ￿g (Lane 3) of CMVHES-i or empty vector (Lane 1). Shown
is the average of two independent experiments. Transfection and f3-galactosidase assays were performed as described in “Materials and Methods.”
that the MASH-i mRNA and protein are decreased by up to
iO-fold in three different clones of Wnt-i/PCi2 cells (clones
2, 4, and 5), relative to wild-type PCi 2 cells or PCi 2 cells
transfected with Wnt-i in the antisense orientation (PCi 2/
Wnt-i antisense; Fig. 2, A and B).
In Drosophila, the hairy and enhancer of split genes,
negatively regulate AS-C HLH protein expression (36-38,
53). Because in mammalian cells the HES-1 gene (hairy
and enhancer split homologue) has a similar function (40,
54), we performed comparisons of HES-i mRNA in PCi 2
and Wnt-i/PCi2 cells. Northern analysis revealed that the
mRNA for the HES-1 gene is strongly induced in mixed
pools and clones of Wnt-i-transformed PC12 cells (Fig.
2C, Lanes 4 and 6-8). Furthermore, in transient transfec-
tion assays, HES-i can repress the transcriptional activity
of a MASH-i promoter-LACZ construct containing a
10-Kb 5’ promoter sequence (46, 55, 56) by up to 75%
(Fig. 2D). These results show that a differentiation-specific
gene, the peripherin gene, is repressed in Wnt-i/PCi2
cells and that proteins binding to a positive regulatory
element of the peripherin promoter, the DPE that contains
a bHLH binding site, are absent. Furthermore, the HLH
protein, MASH-i, is repressed in Wnt-i/PCi2 cells, and a
potential negative regulator of MASH-i ,the HES-1 gene,
is induced.
Increased Growth Rates and Cyclin DI Induction in
Wnt-l/PC12 Cells. One way in which bHLH transcription
factors can regulate cell differentiation is by inhibiting
growth (57, 58), perhaps via antagonism of cyclin Di func-
tion (59-6i). To determine whether cell cycle properties of
PCi 2 are altered by Wnt-i ,we monitored growth in culture
of Wnt-i/PCi2 cells and control PCi2 cells over 8 days
(Fig. 3A). The control cells and Wnt-i/PC12 cell clones 2,
4, and 5, respectively, displayed mean population dou-
bling times of 45, 36.5, 36.5, and 37 h. Flow cytometry
analysis of propidium iodide-stained cell nuclei (Fig. 3B)
revealed that all three Wnt-i clones exhibit a significant
contraction of the G1 phase and expansion of the G2
phase, relative to the controls. Such alterations in cell
cycle phase distribution may result from changes in ex-
pression of the cyclins or changes in the activities of cdks.
Indeed, Wnt-i/PCi2 cells expressed increased levels of
cyclin Di protein and mRNA (Fig. 3C and data not shown),
a change which correlates with the contraction of G1 (62-
64). Activities of kinases controlling progression through
the G1 (cdk4), S (cdk2), or G2 (cdc2) phases were not
significantly altered in Wnt-i/PC12 cells relative to back-
ground, as quantitated by phosphorimager analysis (Fig.
4, A and B). Furthermore, unlike cyclin Di ,the expression
of other cyclins (cyclin A, cyclin E), cdks (cdk2, cdk4,400
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Fig. 4. cdk activities of Wnt-i/PC12 cells. A, G1-specific kinase activity in
Wnt-i/PC12 cells. Immunoprecipitations of cdk4 (Lanes 3 and 4), cyclin Di
(Lanes 5 and 6), or normal rabbit serum (Lanes 1 and 2) from lysates of
Wnt-i/PCi2 cells (Lanes 2, 4, and 6) or control antisense cells (Lanes 1, 3,
and 5) were performed as described in “Materials and Methods.” Immuno-
precipitates were incubated with y 32P-ATP and iO ￿g/ml of bacterially
expressed GST-Rb in anin vitro kinaseassay. Quantitation was performed by
phosphonmager analysis. B, S and G2 phase-specific kinase activities in
Wnt-i/PC12 cells. Immunoprecipitations of cdk2 (Lanes 3 and 4), cyclin E
(Lanes 5 and 6), cdc 2 (Lanes 7 and 8), or normal rabbit serum (Lanes 1 and
2)from lysates ofWnt-i/PC12 cells(Lanes 2, 4, 6, and 8)orcontrol antisense
cells (Lanes 1, 3, 5, and 7) were performed. Immunoprecipitates were incu-
bated with ￿y 32P-ATP and 50 ￿g/ml histone Hi in an in vitm kinase assay.
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Fig. 3. Cell cycle properties of Wnt-i/PC12 cells. A, Wnt-i/PC12 clones
2, 4, and 5 and control antisense Wnt-1 /PC1 2 cells were plated (200,000
cells/i 0-cm plate). After 0, 2, 4, 6, and 8 days, the cells were lysed in buffer
(.1% PBS, .5% Triton X-i00, 2 mM MgCl2, .5% Triton X-i00, 2 mM
MgCI2, and .5% ethylhexadecyl dimethyl ammonium bromide), and nuclei
were counted using a hemacytometer. B, nuclei from Wnt-i/PC12 clones
2, 4, and 5 and control antisense Wnt-i/PCi2 cells were isolated, stained
with propidium iodide, and analyzed by flow cytometry. Nuclei were used
instead of cells because PCi 2 cells tend to aggregate into clumps, which
will be incorrectly analyzed by fluorescence-activated cell sorting as
polyploid nuclei. The distribution of nuclei in the 2n peak (G0-G1 phase),
the 3n area (S phase), and the 4n peak (G2 phase) of the flow cytometry
histograms was quantitated. C, elevated expression of cyclin Di in Wnt-
i/PC12 cells. Protein lysates were prepared from Wnt-i/PCi2 cell clones
2, 4, and 5 (Lanes 3-5), mixed pools ofWnt-1/PC12 cells (MV7Wnt-1; Lane
7) and control Wnt-i/PC12 cells (antisense, MV7fs and PC12; Lanes 2, 6,
and 1, respectively) as described in “Materials and Methods.” Western
analysis was performed using polyclonal cyclin Di antisera at i ug/mI.
HRP-conjugated secondary antibody was used at a 1:5000 dilution. The
HRP immune complexes were detected using an enhanced chemilumi-
nescence kit (Amersham). Nitrocellulose was stained with Ponceau-S to
check protein loading.
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and the expression of several neural and chromaffin markers
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cdk6), or p2i was unchanged in these cells (data not
shown).
Discussion
Altered Expression of Peripherin, MASH-I , and HES-l in
Wnt-I-transformed PCI2 Cells. NGF induces a sympa-
thetic neuronal differentiated state in PCi 2 cells (i ,4). Ec-
topic Wnt-i expression blocks PCi 2 neuronal differentiation
4￿ ii
B
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and induces expression of certain proto-oncogenes and glial
markers (7-9, 3i). In this report, we show that Wnt-i/PCi2
cells express neither the intermediate filament protein, pe-
ripherin, nor factors that bind to the peripherin DPE, which
contains a bHLH binding site. Expression of the MASH-i
gene, a positive regulator of neuronal differentiation, is de-
creased, and expression of the HES-i gene, a negative
regulator, is increased in Wnt-i/PC12 cells relative to control
cells. Proliferation rate and cyclin Di expression are also
increased. These changes recapitulate aspects of the neg-
ative control of neurogenesis in Drosophila and provide a
possible basis for the repression of the differentiated state of
PCi 2 cells by Wnt-i . It is possible that the changes ob-
served in Wnt-i/PC1 2 cells arise from the phenotypic
change induced by Wnt-i transformation. Nevertheless,
studying the characteristics of the altered differentiation
state induced by Wnt-i may provide clues to its function. In
a separate report (97), we analyze the pathway by which
Wnt-i activates HES- 1 gene expression.
Roles of MASH-I and HES-I . The formation of Drosoph-
la sense organs or neuroblasts is controlled by positive-
acting genes of the AS-C and by negative-acting genes
including the hairy/enhancer of split genes (reviewed in Refs.
47 and 65). AS-C heterodimers, with the ubiquitous HLH
protein Daughterless, are necessary and sufficient for son-
sory organ determination (reviewed in Refs. 66 and 67). Hairy
negatively regulates neurogenesis by repressing achaete
gene expression (36-38). The enhancer of split complex
proteins may repress neurogenesis by sequestering AS-C or
Daughterless products as inactive heterodimers (53, 68, 69).
The mammalian MASH-i and HES-i proteins studied in
this report have opposing roles that are analogous to the
roles of AS-C and hairy/enhancer of split in Drosophila.
MASH-i is a neuronal-specific homologue of the AS-C pro-Cell Growth & Differentiation 841
teins (34, 35). It is expressed in forebrain neuroepithelium
and in the peripheral nervous system, at times when precur-
sor cells enter a quiescent, differentiated state (46, 49, 70,
71), and it seems to regulate neuronal differentiation and
possibly cell fate determination (45, 47, 48). HES-i is a
mammalian homologue of the Drosophila hairy and enhancer
of split proteins that regulates neuroepithelial differentiation
in developing brain (39, 40) and is expressed in regions
where neural precursor cells are actively dividing. HES-i
expression decreases with neurogenesis and is not detected
in mature neurons or glial cells (40, 72). In HES-i null mutant
mouse embryos, postmitotic neurons, and differentiation
markers appear prematurely (54, 72), and ectopic HES-i
blocks precursor cell migration from the ventricular zone and
differentiation into neurons (72, 73). These findings suggest
that HES-i must be repressed for precursor cells to enter
differentiation pathways.
Studies in cell lines have provided additional evidence
supporting a role for HES-i in inhibiting differentiation and
allowing precursor cell expansion. HES-i can block the
NGF-induced differentiation of PCi2 cells (74). Overexpres-
sion of HES-i in PCi2 cells inhibits NGF-induced neurite
extension. Conversely, expression of a dominant-negative
HES-i in PCi 2 cells induces neurite outgrowth and periph-
erin expression in the absence of NGF (74). This suggests
that increasing HES-i expression can repress penpherin
expression. Similarly, overexpression of HES-i suppresses
vitamin D3-induced expression of the differentiation-specific
gene osteopontin in rat osteoblastic osteosarcoma cells (75).
The differentiation block imposed by HES-i may be medi-
ated by transcriptional repression of MASH-i in analogy to
the Drosophila model. In human small cell lung cancer cell
lines, induction of HES-i down-regulates expression of the
homologue of MASH-i (hASH-i) by directly binding a class
C site in its promoter (76), thus, providing support for the
Drosophila model.
The decrease in MASH-i expression and increase in
HES-i seen here in Wnt-i -transformed PCi2 cells correlate
with the block in neuronal differentiation of these cells, which
is exemplified by loss of expression of peripherin. The in-
crease in HES-i also correlates with the increased growth
rate, the G1 contraction, and the cyclin Di induction, which
we also observe. It is not yet known whether HES-i is a
direct effector of the morphological and biochemical alter-
ations in Wnt-i/PCi2 cells. To test whether HES-i expres-
sion is sufficient to induce the dedifferentiation of Wnt-i/
PC12 cells, we attempted to express HES-i stably in PCi2
cells. HES-i expression in transformants was, however, rap-
idly lost even when the cells were grown under selection.
HES-i overexpression seems to be toxic to PCi2 cells.
Because PCi 2 transfection efficiency is low, transient trans-
fection will only allow for HES-i expression in a small per-
centage of transfected cells. Transient expression from viral
vectors or inducible expression systems may be required to
surmount this problem.
Increased Growth Rate and Cyclin DI Induction in Wnt-
I/PC12 Cells. Antagonism between growth and differentia-
tion programs may occur at the level of differentiation-spe-
cific HLH regulators and cyclin Di . Cyclin Di encodes a
regulatory subunit of a cyclin Di/cdk complex, which pro-
motes progression through the cell cycle (reviewed in Refs.
77 and 78). Cyclin D1/cdk complexes phosphorylate and
inactivate the tumor suppressor protein pRB (reviewed in
Refs. 79 and 80). Phosphorylated pRB is unable to bind the
E2F-DP family of transcription factors. In the absence of
repression by Rb, the factors are free to activate the expres-
sion of growth stimulatory genes (reviewed in Refs. 81 and
82). Cyclin Dl expression antagonizes the activity of myo-
genic HLH regulators such as MyoD in myocytes; this sup-
pression may be accomplished by phosphorylation of MyoD
by cyclin Di/cdk complexes (83, 84). Conversely, MyoD
exerts growth inhibitory effects (57, 58) partly through the
induction of p2i and the subsequent inhibition of cdk activity
(59-61). Thus, the repression of MASH-i and induction of
cyclin Di in Wnt-i/PCi2 cells may be reinforced by an
analogous antagonism between MASH-i and cyclin Di . In-
terestingly, NGF treatment of PCi 2 cells also induces cyclin
Di . However, NGF decreases the expression and kinase
activities of the cdks and induces the cdk inhibitor p21 . As a
result, cyclin Di/cdk activity is actually diminished by NGF
(6). Wnt-i/PCi2 cells show an induction of cyclin Di ,but no
significant changes in the expression or activities of cdks and
no change in p2i expression. Furthermore, overexpression
of cyclin Di alone has been shown to be sufficient to inhibit
muscle-specific gene expression (85). Thus, the relative ac-
tivities and expression levels of cdks, cyclin Di ,and p21 are
critical for determining G1 phase progression. In the absence
of alterations in p21 expression or cdk expression or activity,
cyclin Di expression promotes G1 phase progression (62,
64, 86). Thus, the elevation of cyclin Di in Wnt-i/PC12 cells
may play a role in the acceleration of G1 phase and increased
growth rate of Wnt-i/PC12 cells. A precedent for these ef-
fects has been seen in ras-, raf-, and src-transformed fibro-
blasts, which also demonstrate increased growth rates, G1
acceleration, and cyclin Di elevation (86). However, these
results must be interpreted with caution. Because PC12 is a
tumor cell line, it may have altered responses to cyclin Di
expression in comparison with neural crest-derived precur-
sors.
HES-I as a Target of Long-Term Wnt-I Signaling.
Wnt-i is expressed in the dorsal central nervous system
during embryogenesis (i 4, 15, 87), and Wnt-i null mutants
show loss of midbrain and cerebellar structures (16-19).
Compound Wnt-iiWnt-3a mutants fail to develop neural pre-
cursors in the dorsolateral neural tube (88). Ectopic Wnt-1
expression in the ventral spinal cord results in an expansion
of the number of mitotic cells in this region (89). Thus, Wnt-1,
like HES-i , may promote neuropeithelial proliferation and
may be required for the expansion of a subset of neuroepi-
thelial cells, which will populate the presumptive midbrain.
Our findings that Wnt-i accelerates growth rate, contracts
G1 phase, and increases cyclin Di expression in PC12 cells
are consistent with a growth stimulatory function for Wnt-1.
Furthermore, evidence suggests that Wnt-i/wg represses
neuronal differentiation by repressing bHLH neuronal deter-
mination genes. Ectopic expression of wg in the Drosophila
eye inhibits expression of achaete, the Drosophila homo-
logue of MASH-i , and sensory organ precursor formation842 Wnt-1 and PCi2 Cell Differentiation
(90). A repressive effect of Wnt-1 on MASH-i is also seen in
P19 embryonal carcinoma cells (91). HES-i elevation and
MASH-i reduction in Wnt-1/PC12 cells seen here raises the
possibility that in development, HES-1 may also be induced
by Wnt-i signals. The broad distribution of HES-1 expres-
sion and the global phenotype of HES-1 null mutants com-
pared with those of Wnt-i would, however, require that
HES-i be a target of other more widespread developmental
signals (besides Wnt-i), such as Notch (92, 93).
Materials and Methods
Plasmids. Dr. R. Kageyama provided the rat HES-i cDNA clone (40). Dr.
Meinrad Busslinger provided the rat MASH-i cDNA clone. Dr. Jane John-
son provided the MASH-i promoter-LACZ construct MIXXSLACZ (55,
56).
Cell Culture. Clones of Wnt-i/PC12 and Wnt-i/PC12 antisense cells
were provided by Dr. Harold Varmus. Mixed populations of 50-iOO clones
of Wnt-i-transformed PC12 cells and PCi2 cells transformed with empty
vector or a vector expressing a frarneShift mutation of Wnt-i were pro-
vided by Dr. Anthony Brown. These cells were infected with a retrovirus
carrying MV7Wnt-i together with a bacterial neomycmn phosphotrans-
ferase resistance gene (7). These cells were cuitured at 37#{176}C, i 0% CO2 in
DMEM (Ufe Technologies, Inc.), supplemented with iO% calf serum and
5% horse serum (Hyclone Laboratories), and 50 ￿g/ml penicillin and
streptomycin. Stable transformant lines were maintained in 250 ￿g/ml
G4i8.
RNA Isolation and Northern Blot Analysis. RNA was isolated by
guanidium thiocyanate-phenol-chloroform single-step extraction (94). To-
tal RNA(30 ￿g)was separated on aformaldehyde-agarosegel and blotted
onto Duralon-UV nylon membranes (Stratagene) as described (95). Blots
were probed by DNA labeled by a ￿P dCTP random priming (Boehringer
Mannheim). Hybridizations were performed for 8 h at 65#{176}C in Quikhyb
solution (Stratagene) and were washed for 30 mm at room temperature in
2 x SSC (300 mM sodium chloride, 30 mM sodium citrate)/0.i % SDS.
High stringency washing was done at 60#{176}C with 0.1 x SSC (i5 mM
sodium chloride, i .5 mM sodium citrate)/0.i % SDS.
CellTranefectlons and ReporterAssays. Lipofection was performed
using Lipofectamine reagent(LifeTechnologies, Inc.), essentially using the
manufacturer’s instructions. Protein extracts were obtained by repeated
freezethawing ofcells suspended in 0.25 M Tris (pH 7.8). p-Galactosidase
assays were performed using a /3-galactosidase assay kit (Tropix Inc.).
￿3-Galactosidase activity was measured as relative light units using a
Lumat LB 9501 luminometer (Berthold).
Nuclear Extract PreparatIon and Gel Retardation Assays. For anal-
ysis of DNA binding activity, nuclear extracts were prepared as described
(96) and DNA-protein binding reactions were performed as described (4i).
DNA-protein complexes were resolved on a 5% potyacrylamide gel [30:
0.8 (acrylamide:bisacrylamide)] using a Tris-glycine-EDTA running buffer
[50 mM Tns (pH 8.5), 0.38 M glycmne, and 1 mM EDTA (pH 8.0)]. For
competition experiments, 50 ng (100-fold molar excess) of unlabeled
wild-type or mutant oligonucleotide was added to the binding reaction.
Oligonucleotide sequences are given in the respective figures. All oligo-
nucleotides were synthesized by Operon Technologies Inc. Annealing of
oligonucleotides was performed by resuspending equimolar amounts of
complementary strands in annealing buffer [iO mM Tris (pH 8.0), 150mM
NaCI, and i5 mM MgCI2J and heating at 95#{176}C for 2’, 68#{176}C for 15’, and
37#{176}C for i5’.
Cell Lysate Preparation. Total cell lysates for immunoblothng were
prepared by harvesting cells from 10-cm dishes and lysing them in 1 ml of
lysis buffer [50 mM HEPES (pH 7.0), 250 mM NaCI, 0.1% NP4O, 10 mM
sodium fluoride, 1 mM phenylmethyl sulfonyl fluoride, 1 ug/rnl leupeptin,
i ug/mI aprotinin, 1 ug/mI pepstatin, and 5 mM Dli]. Protein concentra-
tions were determined by the Bio-Rad protein assay kit, and samples were
adjusted to equal volumes and protein concentration by the addition of
lysis buffer.
Immunoblotting Analyses. Protein lysates (50 ￿g) were mixed with
an equal volume of 2 x sample buffer [4% SDS, 200 mM DTT, i20 mM
Tris (pH 6.8), and 0.02% bromphenol blue]. For Western blotting, proteins
were separated on a i 0% acrylamide gel/5% stack. Samples were trans-
ferred to a nitrocellulose membrane. Blots were incubated in 0.25%
nonfat dry milk In TBST [10 m￿ Tris-HCI (pH 8.0), iSO m￿ NaCI, and .05%
Tween 20] for 2 h with specific antisera and after washing, the secondary
antibody (HRP-conjugated anti rabbit or antirnouse irnmunoglobulln) was
added. Blots were visualized using enhanced chemiluminescence kits
(Amersharn Life Science), followed by exposure to film.
lmmunopreclpitation and In Vitro Kinase Assays. Immunoprecipi-
tations were performed as described previously (3, 6). Lysates were used
immediately and not frozen because freeze-thawing will decrease kinase
activity in thelysates. Lysates were precleared of PAS-binding proteins by
incubation with iO% PAS(wet bead volume:buffervolume; Pharmacia) for
1 h with rocking at 4#{176}C. PAS was removed by centrifugation and antibod-
es were added for i h on ice. Immune complexes were collected by
rocking with 75 ￿I of iO% PAS for 45 mm at 4#{176}C. Sarnples were washed
in lysis buffer as described (3, 6).
In vitro kinase assays were performed as described previously (3, 6).
Immune complexes were washed with kinase buffer [50 mM HEPES (pH
7.5), iO mM MgCI2, and i mM DU] and incubated in a 50-id reaction
containing kinase buffer(ix), 5 ￿Ci ￿,32P-ATP, and iO ￿g/ml of bacterially
expressed GST-Rb or 50 ￿g/ml histone Hi (Boehringer Mannheim). Re-
actions were stopped by the addition of 2 x Laemmli sample buffer.
Histone Hi or GST-Rb was separated from free y 32P-ATP on a iO%
polyacrylamide gel. Phosphorylated histone Hi or GST-Rb was detected
by autoradiography. Quantitation was by phosphorirnager analysis.
Flow Cytometry. Flow cytornetry measurements of cell cycle distri-
bution were performed on cell nuclel to avoid problems of cell aggregation
encountered with PCi2 cells. Cells were lysed in 0.15% NP-40, 50 ug/mI
propidiurn iodide, iOO ug/mI DNasefree RNase A, 5 mM NaCI, and iO mM
trisodium citrate. Concentrations were maintained below 100,000 nu-
cIeVml to prevent aggregation. Nuclel were sorted by flow cytometry
(FACScan; Becton Dickinson). The percentages of G0-G1, 5, and G2-M
phase events were quantitated using the MODFIT program (Modfit Verity
Software House, Topsharn, ME).
Antibodies. MASH-i hybridoma supematant was provided by Dr.
David Anderson. Polyclonalcyclin A, cyclin Di , cyclin E, and odk2 antisera
raised against synthetic peptides were purchased from Upstate Blotech-
nology Inc. Polyclonal antisera to cdk4 raised against synthetic peptides
was purchased from Santa Cruz Biotechnology Inc. Polyclonal odc 2
antibody was raised against a synthetic peptide corresponding to the
COOH-terminal sequences of cdc 2 (CLDNQIKKM). Polyclonal p2i anti-
body was purchased from PharMingen, Inc.
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